Journal Mobile Options
Table of Contents
Vol. 64, No. 2, 2002
Issue release date: 2002
ORL 2002;64:114–119

Etiopathogenesis of Otosclerosis

Niedermeyer H.P. · Arnold W.
Department of Otorhinolaryngology, Head and Neck Surgery, Klinikum r.d. Isar, Technical University, Munich, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Otosclerosis is a frequent cause of nonsyndromic hearing loss which affects exclusively the human temporal bone. Various etiopathogenetic hypotheses have been proposed. The major hypotheses considered are genetic factors, immunologic factors and viral infection. Since the familial incidence of otosclerosis is known a recent genetic analysis has given evidence of three otosclerosis genes (OTSC1–3). Mutations in the collagen gene COL1A1 have been found in one large family with several cases of otosclerosis. Concerning an immunologic etiopathogenetic process, the presence of serum antibodies against collagen II and IX in patients with otosclerosis confirms the hypothesis of a collagen autoimmune mechanism. Finally as a possible cause of this chronic inflammatory disease morphologic and biochemical investigations have revealed a measles virus association. In conclusion, various etiopathogenetic factors may contribute to the genesis of otosclerosis.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Valsalva A: De aurae humana tractatus. Venetiis, Johannes Baptista Morgaganus, 1740.
  2. Toynbee J: Diseases of the ear. Trans Pathol Soc (Lond) 1853;4:257–259.
  3. von Tröltsch A: Treatise on the Diseases of the Ear Including the Anatomy of the Organ. New York, William Wood, 1869.
  4. Politzer A: Über die primären Erkrankungen der knöchernen Labyrinthkapsel. Z Ohrenheilk 1894;25:309–315.
  5. Siebenmann F: Demonstration mikroskopischer Präparate von Otospongiosis. Proc Int Otol Congr 1912;9:207.
  6. Nager FR: Labyrinth malformations in the light of present-day genetics. Pract Otorhinolaryngol (Basel) 1951;13:129.
  7. Ogilvie RF, Hall IS: Observation on the pathology of otosclerosis. J Laryngol Otol 1953;67:497–535.
  8. Ogilvie RF, Hall IS: On the etiology of otosclerosis. J Laryngol Otol 1962;76:841.
  9. Nager GF: Histopathology of otosclerosis. Arch Otolaryngol 1969;89:341–363.

    External Resources

  10. Ruedi L: Otosclerotic lesions and cochlear degeneration. Arch Otolaryngol 1969;89:180–187.
  11. Schuknecht HF: Myths of neurootology. Am J Otol 1992;13:124–126.
  12. Shambaugh GE Jr, Scott A: Sodium fluoride for arrest of otosclerosis. Arch Otolaryngol 1964;80:263.
  13. Podoshin L, Gertner R, Fradis M, Feiglin H, Eibschitz I, Scharf M, Reiter A: Oral contraceptive pills and clinical otosclerosis. Int J Gynaecol Obstet 1978;15:554–556.

    External Resources

  14. Guild IR: Histologic otosclerosis. Ann Otol Rhinol Laryngol 1944;53:246–266.
  15. Soifer NK, Weaver GI, Holdworth GE Jr: Otosclerosis: A review. Acta Otolaryngol 1970(suppl 269):1–25.
  16. Altmann F, Glasgold A, McDuff JP: The incidence of otosclerosis is related to race and sex. Ann Otol Rhinol Laryngol 1967;76:377.

    External Resources

  17. Beales PH: Otosclerosis; in Kerr AG (ed): Scott Brown’s Otolaryngology, ed 5. Edinburgh, Churchill Livingstone, 1987, vol 3, chap 14.
  18. Morrison AW: Otosclerosis: A synopsis of natural history and management. Br Med J 1970;1:345–348.
  19. Mayer O: Untersuchungen über die Otosklerose. Wien, A. Holder, 1917.
  20. Altermatt HJ, Gerber HA, Gaeng D, Müller C, Arnold W: Immunohistochemical findings in otosclerotic lesions. HNO 1992;40:476–479.
  21. Arnold W, Friedmann I: Otosclerosis – An inflammatory disease of the otic capsule of viral aetiology? J Laryngol Otol 1988;102:865–871.
  22. Lim DJ, Robinson M, Saunders WH: Morphologic and immunohistochemical observation of otosclerotic stapes: A preliminary study. Am J Otolaryngol 1987;8:282–295.

    External Resources

  23. Mayer O: Otosclerosis. Zentralbl Hals Nasen Ohrenheilk 1930;18:628.
  24. Sercer A, Krmpotic J: Über die Ursache der progressiven Altersschwerhörigkeit. Acta Otolaryngol Suppl 1958;143:5.
  25. Arnold W, Plester D: Vascular degeneration in otosclerosis and its influence on the mesenchymal reaction of the mucoperiosteum. Arch Otol Rhinol Laryngol 1975;209:127–143.
  26. Arnold W, Plester D: Active otosclerosis of the stapes footplate: Histological and clinical aspects and its influence on the perilymph. Arch Otol Rhinol Laryngol 1977;215:159–178.
  27. Wright I: Avascular necrosis of bone and its relation to fixation of a small joint: The pathology and aetiology of ‘otosclerosis’. J Pathol 1977;123:5–25.

    External Resources

  28. Chevance LG, Causse J, Jorgenson MB, Bretlau P: L’otospongiose: maladie lysosomale cellulaire et enzymatique. Confrontation cytoclinique. Ann Otol Laryngol (Paris) 1972;89:5–34.
  29. Causse J, Chevance LG, Bel J: L’otospongiose: maladie enzymatique cellularie et lysosomale. Confrontation cytoclinique. Ann Otol Laryngol (Paris) 1972;89:563–595.
  30. Causse J, Chevance LG, Bretlau P: Enzymatic concept of otospongiosis and cochlear otosclerosis. Otolaryngology 1977;2:23–32.
  31. Anson BJ, Wilson JG: The fistula ante fenestram in an human adult ear. Anat Rec 1933;56:383–393.
  32. Yoo TJ, Tomoda K, Stuart JM, Kang AH, Townes AS: Type II collagen-induced autoimmune otospongiosis: A preliminary report. Ann Otol Rhinol Laryngol 1983;92:103–108.

    External Resources

  33. Harris JP, Woolf NK, Ryan AF: A reexamination of experimental collagen II autoimmunity: Middle and inner ear morphology and function. Ann Otol Rhinol Laryngol 1986;95:176–180.

    External Resources

  34. Huang CC, Yi Z, Abramson M: Type II collagen-induced otospongiosis-like lesions in the rats. Am J Otolaryngol 1986;7:258–266.

    External Resources

  35. Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda K, Dixit S: Type II collagen autoimmunity in otosclerosis and Menière’s disease. Science 1982;127:1153–1155.
  36. Buija J, Alsalameh S, Jerez R, Sittinger M, Wilmes E, Burmester G: Antibodies to the minor cartilage collagen type IX in otosclerosis. Am J Otol 1994;15:222–224.
  37. Sorensen MS, Nielsen LP, Bretlau P, Jorgensen MB: The role of type II collagen autoimmunity in otosclerosis revisited. Acta Otolaryngol 1988;105:242–247.

    External Resources

  38. Lolov SR, Edrev EG, Kyurkchiev SD, Kehayov IR: Elevated autoantibodies in sera from otosclerotic patients are related to the disease duration. Acta Otolaryngol 1998;118:375–380.
  39. McKenna MJ, Kristiansen AG, Bartley ML, Rogus JJ, Haines JL: Association of COL1A1 and otosclerosis: Evidence for a shared genetic etiology with mild osteogenesis imperfecta. Am J Otol 1998;19:604–610.
  40. Hammerschlag V: Zur Frage der Vererbbarkeit der Otosklerose. Wien Klin Radsch 1905;19:5–7.
  41. Albrecht W: Über die Vererbung der konstitutionell sporadischen Taubstummheit, der hereditären Labyrinthschwerhörigkeit und der Otosklerose. Arch Ohr Nas Kehlkopfheilk 1923;110:15–48.
  42. Morrison AW: Genetic factors in otosclerosis. Ann R Coll Surg Engl 1967;41:202–237.

    External Resources

  43. Tomek MS, Brown MR, Mani SR, Ramesh A, Srisailapathy CR, Coucke P, Zbar RI, Bell AM, McGuirt WT, Fukushima K, Willems PJ, Van CG, Smith RJ: Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum Mol Genet 1998;7:285–290.
  44. Van den Bogaert K, Govaert PJ, Schattemann I, Brown MR, Caethoven G, Offeciers FE, Somers T, Declau F, Coucke P, Van de Heyning P, Smith RJH, Van Camp G: A second gene for otosclerosis, OTSC2, maps to chromosome 7q34-36. Am J Hum Genet 2001;68:495–500.
  45. McKenna MJ, Mills BG: Immunohistochemical evidence of measles virus antigens in active otosclerosis. Otolaryngol Head Neck Surg 1989;101:415–421.
  46. Niedermeyer H, Arnold W, Neubert WJ, Höfler H: Evidence of measles virus RNA in otosclerotic tissue. ORL J Otorhinolaryngol Relat Spec 1994;56:130–132.
  47. McKenna MJ, Kristiansen AG, Haines J: Polymerase chain reaction amplification of a measles virus sequence from human temporal bone sections with active otosclerosis. Am J Otol 1996;17:827–830.
  48. Bozorg Grayeli A, Palmer P, Tran Ba Huy P, Soudant J, Sterkers O, Lebon P, Ferrary E: No evidence of measles virus in stapes samples from patients with otosclerosis. J Clin Microbiol 2000;38:2655–2660.
  49. Arnold W, Niedermeyer HP, Lehn N, Neubert W, Höfler H: Measles virus in otosclerosis and the specific immune response of the inner ear. Acta Otolaryngol 1996;116:705–709.
  50. Niedermeyer HP, Arnold W, Schwub D, Busch R, Wiest I, Sedlmeier R: Shift of the distribution of age in patients with otosclerosis. Acta Otolaryngol 2001;121:197–199.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50